Virus cocktail takes on Antibiotic-Resistant foot infections
Disease control
Completed
This phase 2 trial tested a topical treatment called TP-102, a mix of five viruses that target bacteria, in 76 people with diabetic foot infections. The goal was to see if it is safe and helps heal wounds. The treatment is applied directly to the ulcer every other day.
Phase: PHASE2 • Sponsor: Technophage, SA • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC